A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Clinical trial NCT06961266 · TERMINATED
Trial details
- NCT number
- NCT06961266
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2026-01-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.